PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Nov-2024 Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma Johnson & Johnson
11-Nov-2024 ACG Inspection launches Life Sciences Cloud ACG Inspection
11-Nov-2024 Moberg Pharma’s Nomination Committee appointed Moberg Pharma
11-Nov-2024 Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa Relief Therapeutics Holding SA
08-Nov-2024 SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR Cheplapharm AG
07-Nov-2024 Cherwell highlighting microbiology EM products at Pharmaceutical Microbiology Conference Cherwell
07-Nov-2024 The Accumulus Platform Powers Sanofi’s Submissions to Multiple Regulators Around the World Accumulus Synergy, Inc.
07-Nov-2024 CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 CureVac
07-Nov-2024 Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update Immunic AG
07-Nov-2024 New ultrasonic air bubble de-tector 300 µm AD-102 AMSYS
07-Nov-2024 Bristol Myers Squibb Creates New Leadership Role, Appointing Karen Costello as General Manager for Ireland Bristol Myers Squibb
07-Nov-2024 Genmab Announces Financial Results for the First Nine Months of 2024 Genmab
07-Nov-2024 RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed   RHÖN-KLINIKUM Aktiengesellschaft
07-Nov-2024 Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth Cantourage Group SE
07-Nov-2024 APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted APONTIS PHARMA AG
06-Nov-2024 aap informs about the actual status of the mandatory convertible bond 2023-2028 aap Implantate AG
06-Nov-2024 Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA.
06-Nov-2024 The MAP Group broadens their European market access platform by adding SKC to its portfolio of companies The MAP Group
06-Nov-2024 UK’s medicines manufacturing skills centre welcomes Budget’s £520 million for manufacturing but says the priority must be skills development Innovate UK / Resilience
06-Nov-2024 MHRA grants marketing authorisation to J&J’s bladder cancer therapy BALVERSA®▼ (erdafitinib) Johnson & Johnson